Voices
Mostafa Faisal: MDS/MPN Patients Face Higher Relapse Risks Following Stem Cell Transplantation
Mostafa Faisal/ LinkedIn

Mostafa Faisal: MDS/MPN Patients Face Higher Relapse Risks Following Stem Cell Transplantation

Mostafa Faisal, Adjunct Assistant Professor at Alfaisal University, shared a post on X:

“Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis | Bone Marrow Transplantation.

  • Registry study (n=570): 16.5% had MDS/MPN vs 83.5% MDS
  • MDS/MPN pts older, worse performance status Inferior outcomes vs MDS: OS 41.9% vs 59.7%, RFS 39.2% vs 56.6% (~25 mo)
  • Higher relapse drives worse outcomes; NRM similar (trend increased in MDS/MPN
  • MDS/MPN = independent risk factor for worse RFS.
  • Confirms adverse prognosis – need better transplant strategies.”
Title: Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis

Authors: Adriana Seber, Fabio Pires de Souza Santos, Gisele de Faria, Leonardo Jose Rolim Ferraz, Vaneuza Araujo Moreira Funke, Marcos Augusto Mauad, Carmino Antonio De Souza, Gustavo Werutsky, Nelson Hamerschlak, Liane Esteves Daudt, Andreza Alice Feitosa Ribeiro, Juliana Folloni Fernandes, Samir K. Nabhan, Roberto Luiz Silva

Read the article.

Mostafa Faisal

 

Other articles featuring Mostafa Faisal on OncoDaily.

 

Adriana Seber Andreza Alice Feitosa Ribeiro Bone Marrow Transplantation cancer Carmino Antonio De Souza Fabio Pires de Souza Santos Gisele de Faria Gustavo Werutsky Juliana Folloni Fernandes Leonardo Jose Rolim Ferraz Liane Esteves Daudt Marcos Augusto Mauad MDS Mostafa Faisal Nelson Hamerschlak OncoDaily Oncology Roberto Luiz Silva Samir K. Nabhan Vaneuza Araújo Moreira Funke